Inogen Inc — Director's Dealing 2022

Jan 14, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2022-01-11

Reporting Person: McFarland Loren L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-01-11	Common Stock	M	2083	$8.37	Acquired	22191	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-11	Stock Option (Right to Buy)	$8.37	M	2083	Disposed	2023-10-09	Common Stock (2083)	Direct

Footnotes

F1: Subject to reporting person's continuing to be a Service Provider, 1/12th of the total shares subject to the option shall vest on the first day of each month following the vesting commencement date. The vesting commencement date for this option is October 1, 2013.